What fibrinogen level is used to guide ongoing transfusion therapy?

What fibrinogen level is used to guide ongoing transfusion therapy?

• A. >100 mg/dL
• B. >150 mg/dL
• C. >200 mg/dL
• D. >300 mg/dL

Answer: (C)

In massive obstetric bleeding, fibrinogen is the pivotal clotting factor that gets consumed early. Because it directly underpins the formation of a stable clot, clinicians monitor fibrinogen levels to decide when to replace clotting factors during ongoing transfusion. Keeping fibrinogen above 200 mg/dL (2 g/L) provides enough substrate for effective fibrin formation despite continued bleeding. If levels drop below this target, cryoprecipitate or fibrinogen concentrate is given to raise the level and support hemostasis, rather than waiting for further decline or relying on other factors alone. This threshold balances rapid restoration of clot stability with practical management during transfusion. Other suggested thresholds are lower targets that would not sufficiently support clot formation in active hemorrhage, so 200 mg/dL is the preferred guiding value for ongoing transfusion therapy.

In massive obstetric bleeding, fibrinogen is the pivotal clotting factor that gets consumed early. Because it directly underpins the formation of a stable clot, clinicians monitor fibrinogen levels to decide when to replace clotting factors during ongoing transfusion.

Keeping fibrinogen above 200 mg/dL (2 g/L) provides enough substrate for effective fibrin formation despite continued bleeding. If levels drop below this target, cryoprecipitate or fibrinogen concentrate is given to raise the level and support hemostasis, rather than waiting for further decline or relying on other factors alone. This threshold balances rapid restoration of clot stability with practical management during transfusion.

Other suggested thresholds are lower targets that would not sufficiently support clot formation in active hemorrhage, so 200 mg/dL is the preferred guiding value for ongoing transfusion therapy.